These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30383094)

  • 1. Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications.
    Khan R; Scaffidi MA; Rumman A; Grindal AW; Plener IS; Grover SC
    JAMA Intern Med; 2018 Dec; 178(12):1712-1715. PubMed ID: 30383094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflict of interest reporting in otolaryngology clinical practice guidelines.
    Sun GH
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):187-91. PubMed ID: 23702973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
    Choudhry NK; Stelfox HT; Detsky AS
    JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authorship and industry financial relationships: the tie that binds.
    Johnson DH; Horn L
    J Clin Oncol; 2010 Mar; 28(8):1281-3. PubMed ID: 20065171
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.
    Yamamoto K; Murayama A; Ozaki A; Saito H; Sawano T; Tanimoto T
    Int Urogynecol J; 2021 Feb; 32(2):443-451. PubMed ID: 33151353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Industry Relationships Among Authors of Clinical Practice Guidelines in Gastroenterology.
    Combs TR; Scott J; Jorski A; Heavener T; Vassar M
    JAMA Intern Med; 2018 Dec; 178(12):1711-1712. PubMed ID: 30383088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
    Neuman J; Korenstein D; Ross JS; Keyhani S
    BMJ; 2011 Oct; 343():d5621. PubMed ID: 21990257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
    Grindal AW; Khan R; Scaffidi MA; Rumman A; Grover SC
    Inflamm Bowel Dis; 2019 Mar; 25(4):642-645. PubMed ID: 30295831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial interest and its disclosure in scientific publications.
    Krimsky S; Rothenberg LS
    JAMA; 1998 Jul; 280(3):225-6. PubMed ID: 9676662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
    Shnier A; Lexchin J; Romero M; Brown K
    BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.
    Marušić A; Hren D; Mansi B; Lineberry N; Bhattacharya A; Garrity M; Clark J; Gesell T; Glasser S; Gonzalez J; Hustad C; Lannon MM; Mooney LA; Peña T
    BMC Med; 2014 Oct; 12():197. PubMed ID: 25604352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
    Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
    PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicts of Interest in Clinical Guidelines: Lack of Authors and Disclosures in the AAOMS White Papers.
    Ji YD; Lahey ET
    J Oral Maxillofac Surg; 2018 Sep; 76(9):1946-1949. PubMed ID: 29577870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.
    Bindslev JB; Schroll J; Gøtzsche PC; Lundh A
    BMC Med Ethics; 2013 May; 14():19. PubMed ID: 23642105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    Rose SL; Krzyzanowska MK; Joffe S
    J Clin Oncol; 2010 Mar; 28(8):1316-21. PubMed ID: 20065190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine.
    Hinton J; Reeves T; Shah BN
    Clin Med (Lond); 2021 Mar; 21(2):e166-e170. PubMed ID: 33762382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure unwanted? Exploring the chronic Lyme disease controversy and why conflicts of interest in practice guidelines may be guiding us down the wrong path.
    Ferguson J
    Am J Law Med; 2012; 38(1):196-224. PubMed ID: 22497097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.